Ghezzi, P., Role of glutathione in immunity and inflammation in the lung
Starting the day with a fiber-forward bowl like this aligns with advice to make fruits, vegetables, and whole grains the foundation of meals when using GLP-1s
February 10, 2026: Trulicitys Manufacturer Reports High Revenues, Anticipates Trulicity Sales to Plateau Trulicitys manufacturer, Eli Lilly, announced significant revenue increases in 2025 during its recent earnings call
', '
This was a randomized, head-to-head comparison that enrolled 751 individuals and found those who took tirzepatide lost 20% of their body weight, about 50 pounds on average, while those on semaglutide lost 14% of their body weight, or about 33 pounds on average
Currently in Phase 2 and Phase 3 clinical trials, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from existing licensed weight-loss medicines such as semaglutide and tirzepatide